5
Oct 10 (Reuters) – Johnson & Johnson is in discussions to buy Protagonist Therapeutics, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of Protagonist were up 9.4% in morning trade. (Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
